Literature DB >> 10406184

Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture.

N Kawada1, K Ikeda, S Seki, T Kuroki.   

Abstract

BACKGROUND/AIMS: Regulation of cell cycle progression of cultured rat stellate cells was studied.
METHODS: DNA synthesis was determined by the uptake of [3H]thymidine or 5-bromo-2'-deoxyuridine. Cell cycle distribution was analyzed using FACScan of cellular DNA stained with propidium iodide. Expression of cyclins and cyclin-dependent kinase 4 was evaluated by Western and Northern blotting.
RESULTS: DNA synthesis of primary-cultured stellate cells was found to accelerate 48 h after plating. Cell cycle analysis revealed that more than 93% of the cells were in G0/G1 phase during the first 48 h after plating. The cell population in S phase abruptly increased to about 16% 72 h after culture and shifted to G2/M phase thereafter. The level of proteins and mRNAs for cyclins D1, D2 and E started to increase 48 h after culture with a concomitant expression of platelet-derived growth factor receptor beta, while the level of cyclin-dependent kinase 4 and its mRNA remained unchanged. On the other hand, stellate cells remained in G1 phase when they were cultured in the presence of 3-isobutyl-1-methylxanthine or dibutyryl cAMP after plating. Attenuation of the expression of cyclins D1, D2 and E and platelet-derived growth factor receptor beta, but not cyclin-dependent kinase 4 was found in stellate cells cultured with these agents. Further analysis revealed that LY294002, a selective inhibitor of phosphatidylinositol 3-kinase, suppressed DNA synthesis and cyclin D1 expression in a dose-dependent manner without affecting platelet-derived growth factor receptor beta expression.
CONCLUSIONS: Induction of G1 cyclins may play crucial roles in cell cycle transition of cultured stellate cells from G1 to S. Expression of platelet-derived growth factor receptor beta and activation of phosphatidylinositol 3-kinase may be involved in the process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406184     DOI: 10.1016/s0168-8278(99)80260-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts.

Authors:  Tomohiro Ogawa; Chise Tateno; Kinji Asahina; Hideki Fujii; Norifumi Kawada; Masanobu Obara; Katsutoshi Yoshizato
Journal:  Histochem Cell Biol       Date:  2006-10-06       Impact factor: 4.304

2.  Effects of retinoic acid on proliferation, phenotype and expression of cyclin-dependent kinase inhibitors in TGF-beta1-stimulated rat hepatic stellate cells.

Authors:  Guang-Cun Huang; Jin-Sheng Zhang; Yue-E Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.

Authors:  Pradip B Devhare; Reina Sasaki; Shubham Shrivastava; Adrian M Di Bisceglie; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.

Authors:  Anping Chen; Li Zhang; Jianye Xu; Jun Tang
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

5.  The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis.

Authors:  Xuguang Zhai; Kunfeng Yan; Jiye Fan; Minghui Niu; Qian Zhou; Yan Zhou; Hongshan Chen; Yajun Zhou
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

6.  The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation.

Authors:  Motoki Takashima; Christopher J Parsons; Kenichi Ikejima; Sumio Watanabe; Eric S White; Richard A Rippe
Journal:  J Gastroenterol       Date:  2009-05-13       Impact factor: 7.527

7.  PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.

Authors:  Yuqing Liu; Eric Lik Hang Lui; Scott L Friedman; Lei Li; Tao Ye; Yongjun Chen; Ronnie T Poon; Jana Wo; Tsz Wai Kok; Sheung Tat Fan
Journal:  Lab Invest       Date:  2008-12-29       Impact factor: 5.662

8.  Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.

Authors:  Gakuhei Son; Ian N Hines; Jeff Lindquist; Laura W Schrum; Richard A Rippe
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

9.  PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells.

Authors:  Yajun Zhou; Xin Jia; Guohua Wang; Xin Wang; Jie Liu
Journal:  Mol Cell Biochem       Date:  2009-02-04       Impact factor: 3.396

10.  Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation.

Authors:  Neeraj K Saxena; Mark A Titus; Xiaokun Ding; Jeffrey Floyd; Shanthi Srinivasan; Shanthi V Sitaraman; Frank A Anania
Journal:  FASEB J       Date:  2004-08-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.